Finding 502571 (2023-001)

Significant Deficiency Repeat Finding
Requirement
H
Questioned Costs
-
Year
2023
Accepted
2024-10-12
Audit: 324580
Organization: Okanogan Behavioral Healthcare (WA)

AI Summary

  • Core Issue: Payroll costs were charged to the grant for periods before the allowed performance timeframe.
  • Impacted Requirements: Compliance with §200.309, which mandates that only allowable costs during the grant's performance period can be charged.
  • Recommended Follow-Up: OBHC should create a procedure to ensure payroll transactions align with the grant's performance dates to prevent future issues.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Substance Abuse Prevention and Treatment Block Grant (SABG) Assistance Listing Number: 93.959 Federal Award Identification Number and Year: K6103.01 – 2023 Pass-Through Agency: Washington State Health Care Authority Pass-Through Number(s): K6103.01 Award Period: July 1, 2022 – June 30, 2023 Type of Finding: Significant Deficiency in Internal Control over Compliance – Period of Performance; Other Matters Criteria or specific requirement: Under §200.309, a non-Federal entity may charge to the Federal award only allowable costs incurred during the period of performance applicable to the grant. Condition: During audit procedures performed, we noted two payroll transactions tested included a pay date prior to the beginning period of performance, and the payroll costs were charged to the grant. Questioned costs: None. Context: During audit procedures performed, we tested five payroll transactions for beginning period of performance testing related to ALN 93.959 and noted one of the transactions had a pay period that began prior to the period of performance beginning date for the grant, and the payroll costs incurred prior to the beginning period of performance date were charged to the grant. During payroll testing performed related to allowable costs and activities, of the 10 payroll transactions selected for testing, one was noted in which the pay period was prior to the period of performance beginning date for the grant, and the payroll costs incurred prior to the beginning period of performance date were charged to the grant. Cause: OBHC’s internal controls lacked proper procedures to ensure expenditures were not being charged to the grant if it was not incurred within the period of performance. Effect: OBHC charged expenditures to the grants and was reimbursed for these costs that included payroll costs incurred outside of the contract period of performance. Repeat finding: The finding is a repeat of a finding in the immediate prior year. Prior year finding number was 2022-002. Recommendation: We recommend that OBHC develop a procedure to ensure that payroll transactions are properly allocated to grants and charged to grant awards based on the dates incurred to ensure the costs are within the period of performance. Views of responsible officials: There is no disagreement with the audit finding.

Corrective Action Plan

Action taken in response to finding: The Finance team corrected their processes to ensure proper recording of payroll costs during the time of the FY22 Audit procedures; however, the changes were made to subsequent months and previously submitted months were not retroactively corrected. Additionally, the OBHC team is currently working with the HCA in restructuring the rate schedule to incorporate the payroll costs into the direct service rates for the SOR/SABG grants. This effectively removes this issue going forward in FY25 once approved by the HCA. Name(s) of the contact person(s) responsible for corrective action: Carrie Anthony Planned completion date for corrective action plan: Sep 2023 & New rates: Sep 30, 2024

Categories

Allowable Costs / Cost Principles Period of Performance Significant Deficiency Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 502572 2023-002
    Significant Deficiency
  • 502573 2023-003
    Significant Deficiency
  • 502574 2023-004
    Significant Deficiency
  • 502575 2023-005
    Significant Deficiency
  • 502576 2023-006
    Material Weakness
  • 502577 2023-007
    Significant Deficiency
  • 502578 2023-008
    Material Weakness
  • 502579 2023-002
    Significant Deficiency
  • 502580 2023-005
    Significant Deficiency
  • 502581 2023-007
    Significant Deficiency
  • 502582 2023-002
    Significant Deficiency
  • 502583 2023-006
    Material Weakness
  • 502584 2023-002
    Significant Deficiency
  • 502585 2023-007
    Significant Deficiency
  • 502586 2023-008
    Material Weakness
  • 1079013 2023-001
    Significant Deficiency Repeat
  • 1079014 2023-002
    Significant Deficiency
  • 1079015 2023-003
    Significant Deficiency
  • 1079016 2023-004
    Significant Deficiency
  • 1079017 2023-005
    Significant Deficiency
  • 1079018 2023-006
    Material Weakness
  • 1079019 2023-007
    Significant Deficiency
  • 1079020 2023-008
    Material Weakness
  • 1079021 2023-002
    Significant Deficiency
  • 1079022 2023-005
    Significant Deficiency
  • 1079023 2023-007
    Significant Deficiency
  • 1079024 2023-002
    Significant Deficiency
  • 1079025 2023-006
    Material Weakness
  • 1079026 2023-002
    Significant Deficiency
  • 1079027 2023-007
    Significant Deficiency
  • 1079028 2023-008
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $407,550
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $130,992
14.267 Continuum of Care Program $75,071
93.665 Emergency Grants to Address Mental and Substance Use Disorders During Covid-19 $60,429
93.958 Block Grants for Community Mental Health Services $42,000
93.959 Block Grants for Prevention and Treatment of Substance Abuse $36,000